A phase II study of antiangiogenic therapy (Apatinib) plus chemotherapy as second‐line treatment in advanced small cell lung cancer by Yinghui Xu, Xu Wang, Chao Sun, Zhiru Gao, Hua He, Shi Qiu, Ye Guo, Xiaohui Ma, Junya Song, Kewei Ma

Subjects: Get full text

Comparison of the Efficacy and Safety of PD‐1/PD‐L1 Inhibitors in the Treatment of Small Cell Lung Cancer by Qichen Zhang, Xiaojuan Han, Jiayi Liu, Hui Qiao

Subjects: Get full text

Tarlatamab and the Future of Immunotherapy: A New Approach to Small Cell Lung Cancer by Raza Ur Rehman, MBBS, Ahmad Furqan Anjum, MBBS, Rida Fatima, MBBS

Subjects: Get full text

Atezolizumab in the treatment of small cell lung cancer by Kacper Ordon, Karolina Skonieczna, Olimpia Wiciun, Magdalena Badziąg, Paulina Szulc, Laura Kurczoba, Martyna Kłossowska, Olga Kądziołka

Subjects: “…Small cell lung cancer (SCLC), Immunotherapy, Atezolizumab, Durvalumab, Lurbinectidine, Biomarker-driven therapies, Chemoradiotherapy, Targeted therapies…”
Get full text

Comparison the efficiency of whole brain radiotherapy and simultaneous integrated boost in small cell lung cancer with brain metastases by Xia Shan, Wenqing Wang, Tao Zhang, Wenyang Liu, Jianyang Wang, Xin Wang, Yuqi Wu, Zefen Xiao, Jima Lv, Qinfu Feng, Nan Bi, Zongmei Zhou, Lei Deng

Subjects: “…Small cell lung cancer (SCLC)…”
Get full text

Continuous immunotherapy beyond disease progression in patients with advanced non-small cell and small cell lung cancer by Jing Cheng, Wenwen Kang, Yueying Chen, Luyun Pan, Hedong Han, Tangfeng Lv

Subjects: Get full text